NVRO News and Press, Nevro Corp. From 08/01/23

2023-08-01 20:11:02 ET Nevro Corp. (NVRO) Q2 2023 Earnings Conference Call August 1, 2023 4:30 PM ET Company Participants Greg Chodaczek - Gilmartin Group LLC Kevin Thornal - President and CEO Rod MacLeod - Chief Financial Officer Conference Call Participan...

2023-08-01 16:33:35 ET Nevro press release ( NYSE: NVRO ): Q2 GAAP EPS of -$0.69 in-line. Revenue of $108.8M (+4.4% Y/Y) beats by $0.74M . Nevro expects third quarter of 2023 worldwide revenue of approximately $95 million to $97 million. Company now expects ful...

Nevro Reports Second Quarter 2023 Financial Results, Provides Third Quarter Guidance and Updates Full-Year 2023 Guidance PR Newswire Company Takes Proactive Steps to Improve Commercial Execution and Maximize Growth Opportunities REDWOOD CITY, Calif. , Aug...

Nevro Announces Presentations at American Society of Pain & Neuroscience Fifth Annual Conference Nevro Announces Presentations at American Society of Pain & Neuroscience Fifth Annual Conference PR Newswire Abstract Presentations Highlight Durable Pain Relief and Im...

Nevro to Present at the Canaccord Genuity 43rd Annual Growth Conference PR Newswire Wednesday, August 9, 2023 at 8:30 am Eastern Time REDWOOD CITY, Calif. , July 12, 2023 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical dev...

TORONTO, June 29, 2023 (GLOBE NEWSWIRE) -- EnviroGold Global Limited (CSE:NVRO | OTCQB:ESGLF | FSE:YGK) (“EnviroGold Global” or the “Company”), a clean technology company accelerating the world’s transition to a circular-resource economy, is pleased to announce ...

Nevro to Report Second Quarter 2023 Financial Results PR Newswire Company to Host Conference Call on Tuesday, August 1, 2023 at 1:30 pm PT / 4:30 pm ET REDWOOD CITY, Calif. , June 27, 2023 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO)...

Nevro Announces Painful Diabetic Neuropathy Clinical Data Presentations at the American Diabetes Association 83rd Scientific Sessions PR Newswire Presentation to Discuss Correlation Between Use of High-Frequency (10 kHz) Spinal Cord Stimulation and Reductions in HbA1c and Body...

2023-06-06 14:00:00 ET Nevro ( NYSE: NVRO ) shed ~13% on Tuesday  to reach a new 52-week low after the medical device maker lowered its revenue guidance for Q2 2023, prompting Piper Sandler to warn that a downward revision for its full-year outlook is also on the cards. ...

2023-06-06 10:05:06 ET Gainers: Hoth Therapeutics ( HOTH ) +114% . Zura Bio ( ZURA ) +15% . TScan Therapeutics ( TCRX ) +12% . HealthEquity ( HQY ) +11% . ThermoGenesis ( THMO ) +7% . Losers: HTG Molecular Diagnostics ( ...